Reply
Takahiro Kodama, Tetsuo Takehara – 19 December 2021
Clinical and Ethical Framework for Liver Retransplantation Using Living Donor Grafts: A Western Perspective
Ramesh K. Batra, David C. Mulligan – 19 December 2021
Alcohol Consumption and Cardiovascular Outcomes in Patients With Nonalcoholic Fatty Liver Disease: A Population‐Based Cohort Study
Malik Janjua, Matthew Knuiman, Mark Divitini, Brendan McQuillan, John K. Olynyk, Gary P. Jeffrey, Leon A. Adams – 19 December 2021 – Low‐level alcohol consumption is associated with reduced cardiovascular disease (CVD) in the general population. It is unclear whether this association is seen in patients with nonalcoholic fatty liver disease (NAFLD) who have an increased risk of CVD. We examined the association between alcohol consumption and CVD‐related outcomes in subjects with NAFLD from a general population cohort.
Advances in Predictive Modeling Using Machine Learning in the Field of Hepatology
Camille A. Kezer, Vijay H. Shah, Douglas A. Simonetto – 19 December 2021
Progressive Scale‐up of HBV AND HCV Testing for Hepatitis Elimination in Vietnam
Tran Nguyen, Trang Pham, Loc Phan, Gary Mize, Amy Trang, Diem Dao, Anh Le, Robert Gish, William M. Lee, Dung Do, Hong K. Tang, Hai T. Phan, Binh T. Nguyen, Doan Y Dao – 19 December 2021
Lower Alpha‐Fetoprotein Threshold of 500 ng/mL for Liver Transplantation May Improve Posttransplant Outcomes in Patients With Hepatocellular Carcinoma
Max L. Goldman, Kali Zhou, Jennifer L. Dodge, Francis Yao, Neil Mehta – 19 December 2021 – Under current United Network for Organ Sharing (UNOS) policy, patients with hepatocellular carcinoma (HCC) and alpha‐fetoprotein (AFP) levels ≥1000 ng/mL are required to show a reduction in AFP level to <500 ng/mL before liver transplantation (LT). However, effects of AFP reduction on post‐LT HCC outcomes among patients with HCC with moderately elevated AFP levels between 100 and <1000 ng/mL are unclear.
Loss of bile salt export pump aggravates lipopolysaccharide‐induced liver injury in mice due to impaired hepatic endotoxin clearance
Jelena Remetic, Ahmed Ghallab, Zaynab Hobloss, Lisa Brackhagen, Reham Hassan, Maiju Myllys, Richard Radun, Veronika Mlitz, Ci Zhu, Maximilian Baumgartner, Waltraud C. Schrottmaier, Marion Mussbacher, Gerald Timelthaler, Hubert Scharnagl, Tatjana Stojakovic, Alice Assinger, Claudia D. Fuchs, Jan G. Hengstler, Michael Trauner – 19 December 2021
Letter to the editor: The role of aquaporin 9 in modeling of ornithine transcarbamylase deficiency
Jun‐Wei Zhang, Quan‐Cheng Cheng, Hui‐Ru Ding, Lei Zhang, Yi‐Yao Xu, Xin‐ting Sang, Hai‐Tao Zhao, Wei‐Guang Zhang, Xin Lu – 19 December 2021
Letter to the editor: Etiology and coagulation should be considered more
Guofeng Liu, Xiaoli Fan, Li Yang, Xuefeng Luo – 18 December 2021
Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?
Nicole E. Rich, Amit G. Singal – 18 December 2021 – Overdiagnosis refers to detection of disease that would not otherwise become clinically apparent during a patient’s lifetime. Overdiagnosis is common and has been reported for several cancer types, although there are few studies describing its prevalence in HCC surveillance programs. Overdiagnosis can have serious negative consequences including overtreatment and associated complications, financial toxicity, and psychological harms related to being labeled with a cancer diagnosis.